PPA
APRE icon

Parametric Portfolio Associates’s Aprea Therapeutics APRE Stock Holding History

Parametric Portfolio Associates’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,118
Closed -$777K – 3917
2020
Q1 		$777K Buy
+1,118
New +$820K ﹤0.01% 2939

Other funds holding APRE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Parametric Portfolio Associates's APRE Position: Q2 2020 in Review

Parametric Portfolio Associates sold out of Aprea Therapeutics (APRE) in Q2 2020, closing a stake of 1,118 shares — an estimated $777K sold.

Parametric Portfolio Associates first reported a position in APRE in Q1 2020 and held it in 1 quarter. The position peaked at $777K in Q1 2020. 64 funds tracked by Wall St. Rank hold APRE as of Q2 2020.

  • Parametric Portfolio Associates reported no remaining Aprea Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Parametric Portfolio Associates sold 1,118 Aprea Therapeutics shares in Q2 2020, an estimated $777K.
  • Parametric Portfolio Associates first reported a position in Aprea Therapeutics in Q1 2020 and held it in 1 quarter.
  • Parametric Portfolio Associates's Aprea Therapeutics position peaked at $777K in Q1 2020.
  • 64 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q2 2020.

Based on Parametric Portfolio Associates's 13F filing for Q2 2020, filed 13 Aug 2020.